Treatment with the potent PI3K-,δ,γ inhibitor IPI-145 is associated with rapid decreases in specific cytokines, chemokines and matrix metalloproteinases in the serum of patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma Meeting Abstract


Authors: Douglas, M.; Allison, K.; Ted, S.; Allen, K.; Kahl, B. S.; Horwitz, S. M.; Flinn, I. W.; Kelly, P.; Stern, H. M.
Abstract Title: Treatment with the potent PI3K-,δ,γ inhibitor IPI-145 is associated with rapid decreases in specific cytokines, chemokines and matrix metalloproteinases in the serum of patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma
Meeting Title: 55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 122
Issue: 21
Meeting Dates: 2013 Dec 7-10
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-11-15
Language: English
ACCESSION: WOS:000331385003270
PROVIDER: wos
DOI: 10.1182/blood.V122.21.1633.1633
Notes: Meeting Abstract: 1633 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Steven M Horwitz
    645 Horwitz